| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 12/21/2004 | US6833132 Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity |
| 12/16/2004 | WO2004108923A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 12/16/2004 | WO2004022697A3 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 12/16/2004 | WO2003090514A8 Adipocyte complement related protein zacrp14 |
| 12/16/2004 | WO2003068932A3 Method for crystallizing human gsk3 and novel crystal structure thereof |
| 12/16/2004 | WO2003054184A9 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
| 12/16/2004 | WO2002099084A9 Composite binding polypeptides |
| 12/16/2004 | WO2002070665A8 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 12/16/2004 | US20040254346 Human survivin interacting protein 1 (sip-1) |
| 12/16/2004 | US20040254342 Substrates and assays for beta-secretase |
| 12/16/2004 | US20040254341 Human aspartyl protease peptide for use in identifying modulators for treatment and prevention of neurodegenerative and nervous system disorders; enzyme inhibitors |
| 12/16/2004 | US20040253706 Substrates and assays for beta-secretase |
| 12/16/2004 | US20040253674 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 12/16/2004 | US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders |
| 12/16/2004 | US20040253250 Compositions and methods for regulating lymphocyte activation |
| 12/16/2004 | US20040253247 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands |
| 12/16/2004 | US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease |
| 12/16/2004 | US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis |
| 12/15/2004 | EP1485492A2 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta(1,4)-n-acetylglucosaminyltransferase iii) expression in plants |
| 12/15/2004 | EP1485481A2 Fluorescent protein from aequorea coerulescens and uses thereof |
| 12/15/2004 | EP1485477A2 Novel type-1 cytokine receptor glm-r |
| 12/15/2004 | EP1485476A2 Dimeric tf antagonist |
| 12/15/2004 | EP1485407A1 A mutated immunoglobulin-binding protein |
| 12/15/2004 | EP1485129A2 Nanostructures containing pilin protein |
| 12/15/2004 | EP1485128A2 Nanostructures containing antibody assembly units |
| 12/15/2004 | EP1485126A2 Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 12/15/2004 | EP1485108A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 12/15/2004 | EP1485075A2 Mhc-peptide complex binding ligands |
| 12/15/2004 | EP1263779B1 Self antigen vaccines for treating b cell lymphomas and other cancers |
| 12/15/2004 | EP1121448B1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
| 12/15/2004 | EP0929691B1 Methods and compositions for identifying receptor effectors |
| 12/15/2004 | EP0638088B1 Hybrid human/porcine factor viii |
| 12/15/2004 | CN1555415A Synthetic HCV envelope proteins and their use for vaccination |
| 12/15/2004 | CN1555411A Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 12/15/2004 | CN1555268A Therapeutic agents comprising pro-apoptotic proteins |
| 12/15/2004 | CN1554664A Compounds and methods for diagnosis of tuberculosis |
| 12/15/2004 | CN1179973C HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 12/14/2004 | US6831161 For chromatography; genetic engineering; albumin-binding protein |
| 12/14/2004 | US6831160 Method of affinity purifying proteins using modified bis-arsenical fluorescein |
| 12/14/2004 | US6831060 Nucleotide sequences coding erythropoietin protein for use in the treatment of blood disorders |
| 12/14/2004 | US6830913 ABCB9 transporter and uses thereof |
| 12/14/2004 | CA2104957C Redirection of cellular immunity by receptor chimeras |
| 12/09/2004 | WO2004106525A1 A fusion protein suitable to be expressed high effectively and the production method thereof |
| 12/09/2004 | WO2004106378A2 Method of treating corneal transplant rejection by using vegf antagonists |
| 12/09/2004 | WO2004076479A3 Soluble ctla4 polypeptides and methods for making the same |
| 12/09/2004 | WO2004050692A3 Fusion of the e2 protein of csfv with kdel , vts and/or ubiquitin for expression in transgenic plants for vaccine production |
| 12/09/2004 | WO2003066660A3 A PAIR OF ANTIBODY Fv FRAGMENTS STABILIZED BY COILEDCOIL PEPTIDES |
| 12/09/2004 | WO2002090300A3 Nucleic acids and proteins with thioredoxin reductase activity |
| 12/09/2004 | US20040249892 Secure header information for multi-content e-mail |
| 12/09/2004 | US20040248787 fusion protein comprising a PTD (protein transduction domain) and an MITF (microphthalmia-associated transcripution factor) variant as an active ingredient with a His tag |
| 12/09/2004 | US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators |
| 12/09/2004 | US20040248254 ACPL DNA and polypeptides |
| 12/09/2004 | US20040248196 Methods of screening based on the egf receptor crystal structure |
| 12/09/2004 | US20040248149 Nucleotide sequences coding G-protein coupled receptor (T2R) for use in identifying modulators which control bitterness; food processing and pharmocological design |
| 12/09/2004 | CA2519835A1 Method of treating corneal transplant rejection |
| 12/08/2004 | EP1484338A1 Methods and compositions for inhibiting neoplastic cell growth |
| 12/08/2004 | EP1483408A1 Nanostructures containing pna joining or functional elements |
| 12/08/2004 | EP1483397A2 Oligomeric molecules and uses thereof |
| 12/08/2004 | EP1483384A2 Method for overexpression of zwitterionic polysaccharides |
| 12/08/2004 | EP1483298A2 Materials and methods for preparing dimeric growth factors |
| 12/08/2004 | EP1483297A2 Antibodies derived from anti ed-b l19 and targeting tumor vasculature |
| 12/08/2004 | EP1482984A2 Surrogate antibodies and methods of preparation and use thereof |
| 12/08/2004 | EP1125135B1 A complex of a chaperone with beta-amyloid and methods employing this complex |
| 12/08/2004 | EP0833941A4 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 12/08/2004 | EP0824548B1 Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits |
| 12/08/2004 | CN1553962A System for detecting protease |
| 12/08/2004 | CN1553813A Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B |
| 12/08/2004 | CN1552856A DNA encoding a plasminogen-activating protein |
| 12/08/2004 | CN1178955C Modified TNF alpha molecules and DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA |
| 12/08/2004 | CN1178950C Corpuscles of stannius protein and stanniocalcin |
| 12/07/2004 | US6828418 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 12/07/2004 | US6828416 Recombinant multivalent malarial vaccine against Plasmodium falciparum |
| 12/07/2004 | US6827937 HBV capsid-binding peptide immunogens |
| 12/02/2004 | WO2004104043A1 A synthetic bioelastomer |
| 12/02/2004 | WO2004104042A1 A bioelastomer |
| 12/02/2004 | WO2004104030A2 Peptides modulating the activity of the engrailed transcription factor |
| 12/02/2004 | WO2003085377A3 Novel pancortin-pablo protein interactions and methods of use thereof |
| 12/02/2004 | US20040244070 Expression of polypeptides in rod outer segment membranes |
| 12/02/2004 | US20040242860 Compositions and methods for the diagnosis and treatment of tumor |
| 12/02/2004 | US20040242859 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 12/02/2004 | US20040242844 Nucleotide sequences coding streptococcus capsular polysaccharide antigens for use in diagnosis and prevention of infections in mammals; veterinary medicine |
| 12/02/2004 | US20040241792 Substrates and assays for beta-secretase |
| 12/02/2004 | US20040241684 Directed protein modification by iterative sequence insertion |
| 12/02/2004 | US20040241671 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their us as medicines |
| 12/02/2004 | US20040241640 Internalisation of virus into cells |
| 12/02/2004 | US20040241639 Human tachykinin-related splice variants and compositions thereof |
| 12/02/2004 | US20040241177 Novel compositions and uses therefor |
| 12/02/2004 | US20040241140 Expression vectors able to elicit improved immune response and methods of using same |
| 12/02/2004 | CA2526579A1 Methods for protein labeling based on acyl carrier protein |
| 12/02/2004 | CA2526275A1 Hypoallergenic variants of the parietaria judaica major allergens, uses thereof and compostitions comprising them |
| 12/02/2004 | CA2525954A1 Ura5 gene and methods for stable genetic integration in yeast |
| 12/01/2004 | EP1482046A2 G-CSF analog compositions and methods |
| 12/01/2004 | EP1482045A2 G-CSF analog compositions and methods |
| 12/01/2004 | EP1482044A2 Multivariant IL-3 hematopoiesis fusion protein |
| 12/01/2004 | EP1481065A2 Method for detection of leptin receptor ligands |
| 12/01/2004 | EP0720650B1 Human metabotropic glutamate receptor subtype hmglur7 and related dna compounds |
| 11/30/2004 | US6825325 Fusion proteins; membrane anchoring; genetic engineering; kits |
| 11/30/2004 | US6825008 Expressed ligand—vascular intercellular signalling molecule |
| 11/30/2004 | US6824782 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
| 11/30/2004 | CA2144081C Protection against liver damage by hgf |